• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一株新的、从人粪便中分离得到的不能产生雌马酚的细菌。

sp. nov., an equol non-producing bacterium isolated from human faeces.

机构信息

Microbe Division/Japan Collection of Microorganisms, RIKEN BioResource Research Center, Tsukuba, Ibaraki 305-0074, Japan.

Advanced Genomics Center, National Institute of Genetics, Mishima, Shizuoka 411-8540, Japan.

出版信息

Int J Syst Evol Microbiol. 2021 Dec;71(12). doi: 10.1099/ijsem.0.005121.

DOI:10.1099/ijsem.0.005121
PMID:34870581
Abstract

Two obligately anaerobic, Gram-stain-positive, rod-shaped bacteria were isolated from faecal samples of healthy humans in Japan. 16S rRNA gene sequence analysis indicated that these two strains (8CFCBH1 and 9CBH6) belonged to the genus , which is known as an equol-producing bacterium. The closest neighbours of strain 8CFCBH1 were subsp. DSM 19450 (98.6%), subsp. do03 (98.4%), WCA-131-CoC-2 (96.6%), NR06 (96.4%), B7 (95.3%) and Mt1B8 (95.3%). The closest relatives to strain 9CBH6 were subsp. DSM 19450 (99.8%), subsp. do03 (99.6%) and WCA-131-CoC-2 (96.8%). Strain 8CFCBH1 showed 22.3-53.5% digital DNA-DNA hybridization (dDDH) values with its related species. In addition, the average nucleotide identity (ANI) values between strain 8CFCBH1 and its related species ranged from 75.4 to 93.3%. On the other hand, strain 9CBH6 was considered as based on the dDDH and ANI values (>70% dDDH and >95-96% ANI). Strain 9CBH6 showed daidzein-converting activity, as expected from the result of genome analysis. The genome of strain 8CFCBH1 lacked four genes involved in equol production. Growing cells of strain 8CFCBH1 were not capable of converting daidzein. Based on the collected data, strain 8CFCBH1 represents a novel species in the genus , for which the name sp. nov. is proposed. The type strain of is 8CFCBH1 (=JCM 34083=DSM 112284).

摘要

从日本健康人群的粪便样本中分离到两株严格厌氧、革兰氏阳性、杆状细菌。16S rRNA 基因序列分析表明,这两株菌(8CFCBH1 和 9CBH6)属于 属,该属已知是一种能够产生雌马酚的细菌。菌株 8CFCBH1 的最接近的近缘种是 subsp. DSM 19450(98.6%)、 subsp. do03(98.4%)、WCA-131-CoC-2(96.6%)、NR06(96.4%)、B7(95.3%)和 Mt1B8(95.3%)。菌株 9CBH6 的最接近的亲缘种是 subsp. DSM 19450(99.8%)、 subsp. do03(99.6%)和 WCA-131-CoC-2(96.8%)。菌株 8CFCBH1 与其相关种之间的数字 DNA-DNA 杂交(dDDH)值为 22.3-53.5%。此外,菌株 8CFCBH1 与其相关种之间的平均核苷酸同一性(ANI)值在 75.4%至 93.3%之间。另一方面,根据 dDDH 和 ANI 值,菌株 9CBH6 被认为是 (dDDH 大于 70%,ANI 大于 95-96%)。菌株 9CBH6 表现出大豆黄素转化活性,这与基因组分析的结果一致。菌株 8CFCBH1 的基因组缺乏参与雌马酚生成的四个基因。生长中的菌株 8CFCBH1 不能将大豆黄素转化。基于收集到的数据,菌株 8CFCBH1 代表了 属的一个新种,建议将其命名为 sp. nov.。的模式菌株是 8CFCBH1(=JCM 34083=DSM 112284)。

相似文献

1
sp. nov., an equol non-producing bacterium isolated from human faeces.一株新的、从人粪便中分离得到的不能产生雌马酚的细菌。
Int J Syst Evol Microbiol. 2021 Dec;71(12). doi: 10.1099/ijsem.0.005121.
2
sp. nov., a resveratrol-metabolizing bacterium isolated from human faeces and emended description of the genus .一株新的白藜芦醇代谢菌,从人粪便中分离出来,并对属的描述进行了修正。
Int J Syst Evol Microbiol. 2021 Sep;71(9). doi: 10.1099/ijsem.0.004987.
3
sp. nov., and sp. nov., two new members of the genus isolated from plateau pika ().两新种,即 和 ,从高原鼠兔()中分离得到的该属的两个新成员。
Int J Syst Evol Microbiol. 2024 Oct;74(10). doi: 10.1099/ijsem.0.006531.
4
Isolation of bacteria from the ileal mucosa of TNFdeltaARE mice and description of Enterorhabdus mucosicola gen. nov., sp. nov.从TNFdeltaARE小鼠回肠黏膜中分离细菌并描述黏膜栖居肠杆菌新属、新种
Int J Syst Evol Microbiol. 2009 Jul;59(Pt 7):1805-12. doi: 10.1099/ijs.0.003087-0. Epub 2009 Jun 19.
5
Adlercreutzia equolifaciens gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella.埃格氏菌属的新种——产雌马酚阿德勒克雷茨菌,从人类粪便中分离出的产雌马酚细菌,以及对埃格氏菌属的修订描述
Int J Syst Evol Microbiol. 2008 May;58(Pt 5):1221-7. doi: 10.1099/ijs.0.65404-0.
6
Ellagibacter isourolithinifaciens gen. nov., sp. nov., a new member of the family Eggerthellaceae, isolated from human gut.异尿石生成埃拉吉杆菌,新属,新种,艾氏菌科新成员,从人体肠道分离得到。
Int J Syst Evol Microbiol. 2018 May;68(5):1707-1712. doi: 10.1099/ijsem.0.002735. Epub 2018 Mar 27.
7
sp. nov., sp. nov. and subsp. subsp. nov., isolated from human faeces, and creation of subsp. subsp. nov.新种,新种和亚种亚种,从人类粪便中分离出来,并创建亚种亚种。
Int J Syst Evol Microbiol. 2020 Jan;70(1):473-480. doi: 10.1099/ijsem.0.003778.
8
Slackia equolifaciens sp. nov., a human intestinal bacterium capable of producing equol.迟缓埃格氏菌(Slackia equolifaciens)sp. nov.,一种能够产生雌马酚的人类肠道细菌。
Int J Syst Evol Microbiol. 2010 Aug;60(Pt 8):1721-1724. doi: 10.1099/ijs.0.016774-0. Epub 2009 Sep 4.
9
sp. nov., isolated from human faeces.sp. nov.,从人粪便中分离得到。
Int J Syst Evol Microbiol. 2024 Jun;74(6). doi: 10.1099/ijsem.0.006413.
10
Genome-based, phenotypic and chemotaxonomic classification of strains: proposal of three novel species sp. nov., sp. nov. and sp. nov.基于基因组、表型和化学分类学的 菌株分类:拟议三个新种,即 新种、 新种和 新种。
Int J Syst Evol Microbiol. 2022 Apr;72(4). doi: 10.1099/ijsem.0.005379.

引用本文的文献

1
Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomics.使用鸟枪法宏基因组学对新诊断的炎症性肠病患者的粪便微生物群进行探索。
Front Cell Infect Microbiol. 2025 Jul 1;15:1595884. doi: 10.3389/fcimb.2025.1595884. eCollection 2025.
2
Major depletion of insulin sensitivity-associated taxa in the gut microbiome of persons living with HIV controlled by antiretroviral drugs.抗逆转录病毒药物治疗的 HIV 感染者肠道微生物组中与胰岛素敏感性相关的分类群大量减少。
BMC Med Genomics. 2024 Aug 13;17(1):209. doi: 10.1186/s12920-024-01978-5.
3
Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease.
是一种抗炎共生菌,在代谢性肝病患者的肠道微生物群中丰度降低。
Int J Mol Sci. 2023 Jul 31;24(15):12232. doi: 10.3390/ijms241512232.
4
Update on Accepted Novel Bacterial Isolates Derived from Human Clinical Specimens and Taxonomic Revisions Published in 2020 and 2021.2020 年和 2021 年发表的人源临床标本来源的新分离细菌及其分类学修订的最新进展。
J Clin Microbiol. 2023 Jan 26;61(1):e0028222. doi: 10.1128/jcm.00282-22. Epub 2022 Dec 19.